Abstract:Dendritic cells are powerful antigen-presenting cells that are essential for the priming of T cell responses. In addition to providing T-cell-receptor ligands and co-stimulatory molecules for naive T cell activation and expansion, dendritic cells are thought to also provide signals for the differentiation of CD4+ T cells into effector T cell populations. The mechanisms by which dendritic cells are able to adapt and respond to the great variety of infectious stimuli they are confronted with, and prime an appropriate CD4+ T cell response, are only partly understood. It is known that in the steady-state dendritic cells are highly heterogenous both in phenotype and transcriptional profile, and that this variability is dependent on developmental lineage, maturation stage, and the tissue environment in which dendritic cells are located. Exposure to infectious agents interfaces with this pre-existing heterogeneity by providing ligands for pattern-recognition and toll-like receptors that are variably expressed on different dendritic cell subsets, and elicit production of cytokines and chemokines to support innate cell activation and drive T cell differentiation. Here we review current information on dendritic cell biology, their heterogeneity, and the properties of different dendritic cell subsets. We then consider the signals required for the development of different types of Th immune responses, and the cellular and molecular evidence implicating different subsets of dendritic cells in providing such signals. We outline how dendritic cell subsets tailor their response according to the infectious agent, and how such transcriptional plasticity enables them to drive different types of immune responses.

Human dendritic cell subsets and function in health and disease

Progress on Dendritic Cell Vaccines in Tumor Immunotherapy

Advance in roles of plasmacytoid dendritic cells in viral infection immunity

Progress in Biology of Dendritic Cells——Review

Human dendritic cell subsets: an update

Dendritic Cell Vaccine Design: Strategies for Eliciting Peripheral Tolerance as Therapy of Autoimmune Diseases

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

Transcriptional control of dendritic cell development and functions

Human dendritic cells in cancer

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities

Recent advances in understanding dendritic cell development, classification, and phenotype.

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells

The lifespan and kinetics of human dendritic cell subsets and their precursors in health and inflammation

Dendritic cell subsets and implications for cancer immunotherapy

Tissue-resident dendritic cells and diseases involving dendritic cell malfunction

Dendritic cell subsets in T cell programming: location dictates function

Tolerogenic dendritic cells: the ins and outs of outcome.

The role of dendritic cells in cancer immunity and therapeutic strategies